R&D trends: Biotech assets & discovery platforms
Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.
Funding
- Latest Posts
Best in Biotech 27 Feb 2025
Eight respiratory disease companies advancing innovative therapies in 2025
Discover eight respiratory disease companies advancing their novel therapies through clinical trials in 2025.
In Depth 3 Feb 2025
The biggest biotech funding rounds in January 2025
The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.
News and Trends 31 Jan 2025
U.K. biotech defies the odds, raising £3.5B in 2024
The U.K. biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.
Best in Biotech 21 Jan 2025
14 biotech podcasts to tune into in 2025
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.
In Depth 7 Jan 2025
The biggest private biotech investments in December 2024
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.
ADVERTISEMENT
ADVERTISEMENT
Expert Advice 6 Jan 2025
What to look for in a biotech incubator
Building a biotech startup can be a daunting task and often founders rely on incubators – but how to choose the right one?
In Depth 5 Dec 2024
The biggest private biotech investments in November 2024
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.
Best in Biotech 28 Nov 2024
Six antisense oligonucleotide companies shaping the future of genetic medicine
Learn more about six antisense oligonucleotide companies shaping the future of genetic medicine, just as the market is expected to grow.
Expert Advice 15 Nov 2024
How biotech startups become unicorns
Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation.
Podcast 15 Nov 2024
Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases
This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI).
In Depth 7 Nov 2024
The biggest private biotech investments in October 2024
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.
ADVERTISEMENT
